HGH Therapy
In the late 1980s, the Food and Drug Administration approved Protropin and Humatrope, two prescription injectable synthetic forms of hGH, one from Genentech, who, in 1985, successfully synthesized hGH, through recombinant DNA, called Protropin, and the other one from Eli Lilly, an Indianapolis based pharmaceutical company, who, in 1986, was the first to synthesize a 191 amino acid HGH - Human Growth Hormone molecule, called Humatrope, that matched 100% identical to the hormone made by the human pituitary gland.
In 1996, Humatrope was the first growth hormone therapy to receive FDA approval for treatment of adult growth hormone deficiency.
These forms of injectable HGH are to treat children with small stature. Prescription Hgh injection can boost the growth rate of children deficient in the hGH, preventing extremely short adult stature. These forms of injectable hGH are also used for the elderly who are deficient in hGH.
Injectable hGH is injected into the bloodstream, increasing hGH in the body. Injectable hGH (prescription hGH therapy) is only available through a prescription from your doctor. Prescription hGH therapy is very expensive, costing anywhere from $800 to $2,500 a month, or $10,000 or more a year.
Most people can not afford prescription injectable hGH. Injectable hGH is usually one or two injections a day, and depending on your doctor, the injections can be given by yourself, or your doctor may chose to give you the injections.
Recent research has shown that smaller doses of hGH therapy actually works better than the originally tested larger doses reducing risks of side effects.
|